Monoamine transporter
Top View
- A Practical Guide to the Therapy of Narcolepsy and Hypersomnia Syndromes
- Current and Future Nonstimulants in the Treatment of Pediatric ADHD: Monoamine Reuptake Inhibitors, Receptor Modulators, And
- The Neuronal Monoamine Transporter VMAT2 Is Regulated by the Trimeric Gtpase Go2
- Bupropion Perceived As a Stimulant by Two Patients with a Previous History of Cocaine Misuse
- Structure-Function Analysis of the Dopamine Transporter in the Presence of Synthetic Cathinones and Amphetamines Shari Melissa Radford
- Norepinephrine Transporter As a Target for Imaging and Therapy
- Modeling the Binding of Inhibitors/Drugs to the Human Serotonin Transporter Kalyan Immadisetty
- Structural Basis of Norepinephrine Recognition and Transport Inhibition in Neurotransmitter Transporters
- Pharmacological Profile of Methylphenidate-Based Designer Drugs
- Unique Pharmacodynamic Profile of Methylphenidate: Self- Administration-Induced Dopamine System Alterations
- Reducing Dopamine Leads to Less “Go” and More “Stop” from the Motor Striatum for Robust Therapeutic Effects Stephen M
- Term Behavioral Effects of the Antidepressant Desipramine
- Increased Vesicular Monoamine Transporter Binding During Early Abstinence in Human Methamphetamine Users: Is VMAT2 a Stable Dopamine Neuron Biomarker?
- Human Methamphetamine Pharmacokinetics Simulated in the Rat: Behavioral and Neurochemical Effects of a 72-H Binge
- A Unified Model of Allosteric Modulation and Amphetamine-Induced Substrate Release¶
- Study Drugs”: the Mechanisms of Adhd Medications and Their Abuse on College Campuses
- Exploring the Inhibitory Mechanism of Approved Selective Norepinephrine
- Association of Changes in Norepinephrine and Serotonin Transporter Expression with the Long-Term Behavioral Effects of Antidepressant Drugs